Dermaliq Therapeutics
Dr. Löscher is the CEO, President and co-founder of Dermaliq. Prior to joining Dermaliq, he was Chief Technology Officer of Novaliq GmbH, an ophthalmic drug development company. There he was instrumental in the development of several drug candidates and products such as NOV03, CyclASol, EvoTears/NovaTears. He is inventor and co-inventor of numerous drug candidates and developed the pipeline and business case for Dermaliq. Dr. Löscher graduated as a chemist from the University of Heidelberg and received his Dr. rer. nat. degree from the University of Regensburg.
This person is not in any teams
This person is not in any offices
Dermaliq Therapeutics
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients